NFL Biosciences

ISIN: FR0014003XT0 | Ticker: ALNFL | LEI: 9695006VJWNTN4UNHA27

Sector: Health Care – Sub-Industry: Biotechnology

Country: France

About NFL Biosciences

Company Description

Making it possible to cure smoking addiction

NFL Biosciences develops a naturally based addiction withdrawal solution to help smokers willing to quit in their battle for a healthier life.

NFL Biosciences is a biotechnology company pioneering innovative solutions through a breakthrough approach based on a standardized extract of tobacco leaf. NFL-101 is NFL Biosciences current core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

Year founded

2006

Served area

Worldwide

Headquarters

199 Rue Hélène Boucher, 34170 Castelnau-le-Lez – France